You have full text access to this OnlineOpen article

Cancer

Cover image for Cancer

1 August 2001

Volume 92, Issue 3

Pages 453–711

  1. Original Articles

    1. Top of page
    2. Original Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    1. Disease Site

      Blood/Bone Marrow
      You have full text access to this OnlineOpen article
      Advanced hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy : A study of 82 patients from the groupes d'etudes des lymphomes de l'adulte h89 trial (pages 453–459)

      Pauline Brice, Philippe Colin, Françoise Berger, Eric de Kerviler, Marine Diviné, Fadellah Bouaffia, Yves Kerneis, Michel Blanc, Eric Lepage and Christophe Fermé

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<453::AID-CNCR1343>3.0.CO;2-8

      Patients with advanced Hodgkin disease and large mediastinal involvement can be treated with eight cycles of chemotherapy alone without radiotherapy when a major response has been obtained after six cycles. A study of 82 patients with large mediastinal involvement among 533 included in the H89 Groupes d'Etudes des Lymphomes de l'Adulte clinical trial.

  2. Original Article

    1. Top of page
    2. Original Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    1. Disease Site

      Blood/Bone Marrow
      You have full text access to this OnlineOpen article
      Receptor activator of nuclear factor-κB ligand and osteoprotegerin : Potential implications for the pathogenesis and treatment of malignant bone diseases (pages 460–470)

      Lorenz C. Hofbauer, Andreas Neubauer and Armin E. Heufelder

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<460::AID-CNCR1344>3.0.CO;2-D

      Receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) are key regulators of osteoclast functions, including differentiation, survival, fusion, activation, and apoptosis. These compounds play important roles in the regulation of bone resorption and calcium homeostasis. Abnormalities of the RANKL/OPG system have been implicated in the pathogenesis of various primary and secondary bone malignancies. Moreover, systemic administration of OPG appears to emerge as a potent novel therapeutic modality for these disorders.

    2. Breast Disease
      You have full text access to this OnlineOpen article
      Improved accuracy in differentiating malignant from benign mammographic abnormalities : A simple, improved magnetic resonance imaging method (pages 471–478)

      Vijay P. Khatri, James J. Stuppino, Manuel H. Espinosa and Matthew S. Pollack

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<471::AID-CNCR1345>3.0.CO;2-6

      Magnetic resonance breast imaging has been increasingly accepted as an alternative imaging modality in radiologically difficult cases but has been limited because of its low specificity. A simple method of magnetic breast imaging with increased specificity (94% specificity and sensitivity) was found to discriminate malignant from benign mammographic abnormalities.

    3. You have full text access to this OnlineOpen article
      Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history (pages 479–487)

      Sharon N. Teraoka, Kathleen E. Malone, David R. Doody, Nicola M. Suter, Elaine A. Ostrander, Janet R. Daling and Patrick Concannon

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<479::AID-CNCR1346>3.0.CO;2-G

      Mutations in the ATM gene, specifically those predicted to result in amino acid substitutions, were significantly increased in breast carcinoma cases selected for positive family history.

    4. Gastrointestinal Tract
      You have full text access to this OnlineOpen article
      The association of k-ras gene mutation and vascular endothelial growth factor gene expression in pancreatic carcinoma (pages 488–499)

      Naoya Ikeda, Yoshiyuki Nakajima, Masayuki Sho, Masashi Adachi, Cheng-long Huang, Katsumichi Iki, Hiromichi Kanehiro, Michiyoshi Hisanaga, Hiroshige Nakano and Masayuki Miyake

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<488::AID-CNCR1347>3.0.CO;2-F

      In this study, the authors investigated the mechanism underlying the regulation of vascular endothelial growth factor (VEGF) expression and evaluated VEGF gene expression and K-ras gene status in specimens from 48 patients with pancreatic carcinoma. The results suggest that K-ras oncogene mutation may be associated with VEGF gene expression and that patients with pancreatic carcinoma who have high levels of VEGF gene expression were associated with a poor prognosis.

    5. You have full text access to this OnlineOpen article
      2-methoxyestradiol-induced caspase-3 activation and apoptosis occurs through G2/M arrest dependent and independent pathways in gastric carcinoma cells (pages 500–509)

      Heng-Liang Lin, Tsung-Yun Liu, Chew-Wun Wu and Chin-Wen Chi

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<500::AID-CNCR1348>3.0.CO;2-4

      2-Methoxyestradiol-induced gastric carcinoma cell apoptosis occurs through caspase-3 and caspase-8 activation. Reactive oxygen species formation maybe responsible for G2/M-phase arrest induced by 2-methoxyestradiol. Calcium modulators (A23187 and thapsigargin) partially reversed G2/M arrest, resulting in differential caspase-3 activation, suggesting that G2/M arrest is not a prerequisite for caspase-3 activation. This endogenous estrogen metabolite may hold potential use in the treatment of patients with gastric carcinoma by the direct activation of caspases in tumor cells.

    6. Genitourinary Disease
      You have full text access to this OnlineOpen article
      Prognostic significance of thymidylate synthase activity in bladder carcinoma (pages 510–518)

      Yoichi Mizutani, Hiromi Wada, Osamu Ogawa, Osamu Yoshida, Masakazu Fukushima, Norio Nonomura and Tsuneharu Miki

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<510::AID-CNCR1349>3.0.CO;2-0

      The level of thymidylate synthase activity correlated with both the progression of the stage and the increase of the grade of bladder carcinoma. In addition, the elevated thymidylate synthase activity was associated with early recurrence in Ta and T1 bladder carcinoma.

    7. You have full text access to this OnlineOpen article
      Phase II evaluation of paclitaxel, α-interferon, and cis-retinoic acid in advanced renal cell carcinoma (pages 519–523)

      Ulka Vaishampayan, Lawrence Flaherty, Wei Du and Maha Hussain

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<519::AID-CNCR1350>3.0.CO;2-#

      This study is a report of a Phase II clinical trial of paclitaxel, α-interferon, and cis-retinoic acid in advanced renal cell carcinoma. This was a well tolerated regimen with minimal clinical efficacy.

    8. You have full text access to this OnlineOpen article
      The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma : An evaluation from a randomized, population-based study of screening for prostate cancer (pages 524–534)

      André N. Vis, Robert F. Hoedemaeker, Monique Roobol, Fritz H. Schröder and Theo H. van der Kwast

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<524::AID-CNCR1351>3.0.CO;2-A

      Data from a population-based, randomized clinical trial in which participants were screened for prostate carcinoma according to well standardized protocols clarified that men with isolated, high-grade prostatic intraepithelial neoplasia on initial biopsy are at no greater risk of being diagnosed with prostate carcinoma on repeated biopsy than if their initial biopsies were assessed as benign only. However, men with a prostate biopsy suspicious for malignancy are at considerable risk of having malignant disease on repeated biopsy, and the tumor characteristics of the malignancies detected indicate that these may resemble the cancers/carcinomas found on initial biopsy.

    9. Gynecologic Oncology
      You have full text access to this OnlineOpen article
      Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma (pages 535–541)

      Philip I. Haigh, Anthony Lucci, Roderick R. Turner, Peter J. Bostick, David L. Krasne, Stacey L. Stern and Donald L. Morton

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<535::AID-CNCR1352>3.0.CO;2-3

      Carbon dye was used with isosulfan blue dye and radiocolloid for lymphatic mapping of the sentinel lymph nodes (SNs) in patients with cutaneous melanoma. Carbon particles were visualized in SNs from 96 of 100 patients and in all tumor-positive SNs. Carbon dye provides a histopathologic marker to help the pathologist confirm that the SN has been identified correctly.

    10. You have full text access to this OnlineOpen article
      Loss of motility-related protein 1 (MRP1/CD9) and integrin α3 expression in endometrial cancers (pages 542–548)

      Shingo Miyamoto, Akiko Maruyama, Kaoru Okugawa, Kohei Akazawa, Hideo Baba, Yoshihiko Maehara and Eisuke Mekada

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<542::AID-CNCR1353>3.0.CO;2-8

      Each reduced expression of MRP1/CD9 and integrin α3 was strikingly correlated with histologic grade and metastasis in endometrial cancer. The expression of MRP1/CD9 was regarded as a significant prognostic factor in disease-free survival.

    11. Head and Neck Disease
      You have full text access to this OnlineOpen article
      Demographic variations in the rising incidence of esophageal adenocarcinoma in white males (pages 549–555)

      Elfriede Bollschweiler, Eva Wolfgarten, Christian Gutschow and Arnulf H. Hölscher

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L

      This study compares the rise in the incidence of adenocarcinoma of the esophagus both for the United States and for Europe and Australia. The relatively short period of 2 decades for the increase provides hard evidence for an influence of environmental factors.

    12. You have full text access to this OnlineOpen article
      Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis (pages 556–568)

      Pornchai O-charoenrat, Peter Rhys-Evans and Suzanne A. Eccles

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<556::AID-CNCR1355>3.0.CO;2-Q

      The expression of vascular endothelial growth factor family members has appeared to be a common feature in both experimental and clinical models of head and neck squamous cell carcinoma (HNSCC). The differential expression patterns of these angiogenic factors were found to have importance in the promotion of HNSCC growth and progression by way of lymphatic spread.

    13. Hepatobiliary Tract
      You have full text access to this OnlineOpen article
      Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma (pages 569–577)

      Philip A. Philip, Mark M. Zalupski, V. K. Vaitkevicius, Patricia Arlauskas, Ruth Chaplen, Lance K. Heilbrun, Volkan Adsay, Donald Weaver and Anthony F. Shields

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<569::AID-CNCR1356>3.0.CO;2-D

      The combination of 2′-deoxy-2′,2′-difluorocytidine (gemcitabine) and cisplatin appears to have greater antitumor activity and more prolonged survival than single-agent gemcitabine in the treatment of patients with locally advanced and metastatic carcinoma of the pancreas with a manageable but not insignificant level of hematologic toxicity.

    14. You have full text access to this OnlineOpen article
      Multimodality treatment of patients with liver metastases from germ cell tumors : The role of surgery (pages 578–587)

      Michel Rivoire, Dominique Elias, Franco De Cian, Pierre Kaemmerlen, Christine Théodore and Jean Pierre Droz

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<578::AID-CNCR1357>3.0.CO;2-C

      Indication for resection of liver metastases in patients with germ cell tumors is dependent on the size of the postchemotherapy residual liver mass, the histologic type of the primary tumor, and patient's gender.

    15. Lung Disease
      You have full text access to this OnlineOpen article
      A case–control study for evaluating the efficacy of mass screening program for lung cancer in miyagi prefecture, Japan (pages 588–594)

      Motoyasu Sagawa, Yoshitaka Tsubono, Yasuki Saito, Masami Sato, Ichiro Tsuji, Satomi Takahashi, Katsuo Usuda, Tatsuo Tanita, Takashi Kondo and Shigefumi Fujimura

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<588::AID-CNCR1358>3.0.CO;2-8

      A case–control study was conducted to evaluate the efficacy of a mass screening program for lung cancer in Miyagi Prefecture, Japan. The results revealed that annual screening could reduce by 46% the risk of death from carcinoma of the lung.

    16. You have full text access to this OnlineOpen article
      Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma : A study of the national cancer institute of Canada clinical trials group (pages 595–600)

      Frances A. Shepherd, Janet Dancey, Andrew Arnold, Alan Neville, James Rusthoven, Robert D. Johnson, Bryn Fisher and Elizabeth Eisenhauer

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<595::AID-CNCR1359>3.0.CO;2-D

      The combination of pemetrexed disodium and cisplatin resulted in a response rate of 45% in 29 evaluable patients with nonsmall cell lung carcinoma. The median survival rate was 8.9 months with 49% 1-year survival rate, and the regimen was well tolerated in both patients with Stage IV disease and those with performance status of 2 with a median of 6 cycles of treatment delivered.

  3. Original Articles

    1. Top of page
    2. Original Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    1. Disease Site

      Lung Disease
      You have full text access to this OnlineOpen article
      Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma (pages 601–608)

      Shane C. White, Paul Lorigan, Mark R. Middleton, Heather Anderson, Juan Valle, Yvonne Summers, Paul A. Burt, Ana Arance, Ron Stout and Nick Thatcher

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<601::AID-CNCR1360>3.0.CO;2-K

      Single-agent carboplatin is well tolerated in patients with poor prognosis small cell lung carcinoma and has efficacy similar to that of combination chemotherapy with cyclophosphamide, doxorubicin, and vincristine.

  4. Original Article

    1. Top of page
    2. Original Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    1. Disease Site

      Skin and Soft Tissue
      You have full text access to this OnlineOpen article
      High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma (pages 609–619)

      Steven J. O'Day, Peter D. Boasberg, Tim S. Kristedja, Maureen Martin, He-Jing Wang, Patricia Fournier, Myles Cabot, Michael W. DeGregorio and Guy Gammon

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<609::AID-CNCR1361>3.0.CO;2-U

      In the current study, the addition of high-dose tamoxifen to a regimen of concurrent biochemotherapy for patients with metastatic melanoma did not appear to improve treatment response or overall survival, despite the attainment of in vivo plasma concentrations known to elicit tumor cell chemosensitization in vitro.

    2. Discipline

      Translational Research
      You have full text access to this OnlineOpen article
      Tumor necrosis factor α negatively regulates the expression of the carcinoma-associated antigen epithelial cell adhesion molecule (pages 620–628)

      Olivier Gires, Cuong Kieu, Peter Fix, Bärbel Schmitt, Markus Münz, Barbara Wollenberg and Reinhard Zeidler

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<620::AID-CNCR1362>3.0.CO;2-F

      The expression of the carcinoma-associated antigen epithelial cell adhesion molecule is regulated negatively by tumor necrosis factor α (TNFα) and 12-O-tetradecanoylphorbol-13-acetate through the activation of nuclear factor κB (NF-κB). The repression may rely on the competition of NF-κB for p300/CREB binding protein histone acetyl transferase activity, because the overexpression of p300 reverts TNFα effects.

    3. You have full text access to this OnlineOpen article
      Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia : A north central cancer treatment group exploratory investigation (pages 629–633)

      Aminah Jatoi, Charles L. Loprinzi, Jeff A. Sloan, George G. Klee and Harold E. Windschitl

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<629::AID-CNCR1363>3.0.CO;2-M

      Neuropeptide Y, leptin, and cholecystokinin 8 have been implicated in cancer-associated anorexia. To date, however, no assessment of circulating concentrations of these hormones has been undertaken in cancer patients with advanced disease and anorexia. In this trial, the authors explored potential correlations between these three hormones and cancer-associated anorexia.

    4. You have full text access to this OnlineOpen article
      Expression of glucose transporter-1 in human gastric carcinoma : Association with tumor aggressiveness, metastasis, and patient survival (pages 634–641)

      Tetsuo Kawamura, Takashi Kusakabe, Takashi Sugino, Kazuo Watanabe, Takeaki Fukuda, Atsushi Nashimoto, Keiichi Honma and Toshimitsu Suzuki

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X

      In human gastric carcinoma, the expression of glucose transporter-1 (Glut1) was associated closely with histologic subtype (high in well differentiated, low in mucin-producing type), depth of invasion, lymphatic permeation, venous invasion, lymph node metastasis, hepatic metastasis, and carcinoma stage. Patient survival was significantly high in Glut1-negative cases.

    5. Medical Oncology
      You have full text access to this OnlineOpen article
      Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas : Results of a Phase II trial (pages 642–649)

      John D. Hainsworth, Howard A. Burris III, Anthony A. Meluch, Margaret N. Baker, Lisa H. Morrissey and F. Anthony Greco

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<642::AID-CNCR1365>3.0.CO;2-Z

      The combination of paclitaxel, carboplatin, and long-term infusional 5-fluorouracil is feasible, well tolerated, and highly efficacious in patients with advanced squamous carcinomas of various primary sites.

    6. You have full text access to this OnlineOpen article
      Combined regimen of cisplatin, doxorubicin, and α-2b interferon in the treatment of advanced malignant pleural mesothelioma : A Phase II multicenter trial of the Italian group on rare tumors (GITR) and the italian lung cancer task force (FONICAP) (pages 650–656)

      Héctor Soto Parra, Lucia Tixi, Fiorenza Latteri, Sergio Bretti, Marco Alloisio, Adriano Gravina, Rita Lionetto, Paolo Bruzzi, Carla Dani, Riccardo Rosso, Maurizio Cosso, Luca Balzarini, Armando Santoro and Andrea Ardizzoni

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<650::AID-CNCR1366>3.0.CO;2-0

      Combined regimen of cisplatin, doxorubicin, and α-2b interferon is active in malignant pleural mesothelioma, but toxicity may limit its application.

    7. Surgical Oncology
      You have full text access to this OnlineOpen article
      Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa (pages 657–662)

      Alessandro Beghini, MariaGrazia Tibiletti, Gaia Roversi, AnnaMaria Chiaravalli, Giovanni Serio, Carlo Capella and Lidia Larizza

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D

      C-kit germline mutation in the juxtamembrane domain leads to a syndrome characterized by multiple gastrointestinal stromal tumors and urticaria pigmentosa.

    8. You have full text access to this OnlineOpen article
      Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma (pages 663–669)

      Hideaki Shimada, Akihiko Takeda, Yoshihiro Nabeya, Shin-ichi Okazumi, Hisahiro Matsubara, Yutaka Funami, Hideki Hayashi, Yoshio Gunji, Susumu Kobayashi, Takao Suzuki and Takenori Ochiai

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<663::AID-CNCR1368>3.0.CO;2-L

      Vascular endothelial growth factor (VEGF) has been reported to be a potent inducer of angiogenesis in malignant tumors. Increased serum VEGF concentration (S-VEGF) has been found in patients with various solid tumors and appears to be correlated with tumor burden. In the current study, high S-VEGF was found to be associated with tumor progression, poor patient response to treatment, and poor survival in patients with esophageal squamous cell carcinoma.

    9. Radiation Oncology
      You have full text access to this OnlineOpen article
      Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy (pages 670–676)

      Gregory M. Chronowski, Chul S. Ha, Richard B. Wilder, Fernando Cabanillas, John Manning and James D. Cox

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<670::AID-CNCR1369>3.0.CO;2-Q

      Surgery results in excellent rates of cure in patients with unicentric Castleman disease; radiotherapy also can achieve clinical response and cure in selected patients. Multicentric Castleman disease is a more aggressive clinical entity and is treated most effectively with combination chemotherapy, whereas the role of radiotherapy in its treatment remains unclear.

    10. Pediatric Oncology
      You have full text access to this OnlineOpen article
      Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas (pages 677–683)

      Anirban Maitra, Dana Wanzer, Arthur G. Weinberg and Raheela Ashfaq

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<677::AID-CNCR1370>3.0.CO;2-V

      Amplification of the HER-2/neu oncogene, as assessed by fluorescent in situ hybridization on archival tissue, was shown to be uncommon in high-grade pediatric osteosarcomas.

    11. You have full text access to this OnlineOpen article
      A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL s® in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation (pages 684–690)

      Menachem Oberbaum, Isaac Yaniv, Yael Ben-Gal, Jerry Stein, Nurit Ben-Zvi, Laurence S. Freedman and David Branski

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<684::AID-CNCR1371>3.0.CO;2-#

      A randomized, placebo-controlled, double-blind clinical trial was conducted in 32 patients ages 3–25 years who had undergone allogeneic or autologous stem cell transplantation. This study indicates that the homeopathic medication TRAUMEEL S® may significantly reduce the severity and duration of chemotherapy-induced stomatitis in children undergoing bone marrow transplantation.

    12. You have full text access to this OnlineOpen article
      Informed consent for pediatric leukemia research : Clinician perspectives (pages 691–700)

      Chris Simon, Michelle Eder, Pauline Raiz, Stephen Zyzanski, Rebecca Pentz and Eric D. Kodish

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<691::AID-CNCR1372>3.0.CO;2-4

      Clinician perspectives on informed consent for pediatric research were obtained from five major medical centers that routinely enroll patients in Children's Cancer Group studies. Clinicians report a range of approaches, opinions, concerns, and suggestions for improving the informed consent process.

    13. Pathology
      You have full text access to this OnlineOpen article
      Clinicopathologic assessment and grading of embolized meningiomas : A correlative study of 64 patients (pages 701–711)

      Arie Perry, Michael R. Chicoine, Eric, Filiput, J. Philip Miller and DeWitte T. Cross

      Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<701::AID-CNCR1373>3.0.CO;2-7

      Preoperative embolization of meningiomas increases the likelihood of necrosis, reactive/reparative atypia, and proliferative activity on histopathologic examination, thereby leading to potential overgrading as atypical meningioma. Recently proposed grading criteria minimize this possibility and correlate well with biologic behavior in embolized meningiomas. Only a rough association was found between the extent of necrosis and either postembolization angiographic findings or particle size utilized.

SEARCH

SEARCH BY CITATION